Discounted Cash Flow Rating
Sell
Return on Equity Rating
Sell
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Strong Buy
Analyst Rating
Buy
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Protalix BioTherapeutics, Inc. Common Stock (PLX)
Biological Products, (no Disgnostic Substances)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substance to Pfizer under its Amended Pfizer Agreement.
2 UNIVERSITY PLAZA, SUITE 100
HACKENSACK, NJ
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
03/12/2007
Market Cap
71,262,876
Shares Outstanding
72,950,000
Weighted SO
72,952,124
Total Employees
N/A
Upcoming Earnings
08/05/2024
Beta
0.7820
Last Div
0.0000
Range
0.82-2.05
Chg
0.0190
Avg Vol
436883
Mkt Cap
71262876
Exch
AMEX
Country
US
Phone
201 696 9345
DCF Diff
1.3356
DCF
-0.0056
Div Yield
0.0000
P/S
1.8727
EV Multiple
-5.3514
P/FV
2.4854
Div Yield %
0.0000
P/E
-4.8343
PEG
-0.5133
Payout
0.0000
Current Ratio
1.3346
Quick Ratio
0.9772
Cash Ratio
0.4036
DSO
97.1274
DIO
293.0381
Op Cycle
390.1656
DPO
57.4790
CCC
332.6866
Gross Margin
0.3218
Op Margin
-0.3885
Pretax Margin
-0.3981
Net Margin
-0.3861
Eff Tax Rate
0.0301
ROA
-0.1605
ROE
-0.4515
ROCE
-0.4404
NI/EBT
0.9699
EBT/EBIT
1.0247
EBIT/Rev
-0.3885
Debt Ratio
0.2857
D/E
0.9150
LT Debt/Cap
0.1303
Total Debt/Cap
0.4778
Int Coverage
-9.1041
CF/Debt
-0.1038
Equity Multi
3.2028
Rec Turnover
3.7579
Pay Turnover
6.3501
Inv Turnover
1.2456
FA Turnover
3.6805
Asset Turnover
0.4157
OCF/Share
-0.0370
FCF/Share
-0.0570
Cash/Share
0.6142
OCF/Sales
-0.0713
FCF/OCF
1.5403
CF Coverage
-0.1038
ST Coverage
-0.1241
CapEx Coverage
-1.8507
Div&CapEx Cov
-1.8507
P/BV
2.4854
P/B
2.4854
P/S
1.8727
P/E
-4.8343
P/FCF
-17.0404
P/OCF
-26.1642
P/CF
-26.1642
PEG
-0.5133
P/S
1.8727
EV Multiple
-5.3514
P/FV
2.4854
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
263.96K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
64.52K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
1.65M Shares Bought (100.00 %)
0.00 Shares Sold (0.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 27.02M | ▼ 17.76M | ▲ 19.50M | ▼ 8.55M | ▲ 8.62M | ▲ 10.49M | ▼ 3.75M |
Cost Of Revenue | 2.28M | ▲ 2.95M | ▼ 2.75M | ▲ 3.15M | ▼ 2.40M | ▲ 8.86M | ▼ 2.60M |
Gross Profit | 24.74M | ▼ 14.81M | ▲ 16.74M | ▼ 5.40M | ▲ 6.22M | ▼ 1.63M | ▼ 1.15M |
Gross Profit Ratio | 0.92 | ▼ 0.83 | ▲ 0.86 | ▼ 0.63 | ▲ 0.72 | ▼ 0.16 | ▲ 0.31 |
Research And Development Expenses | 9.58M | ▲ 9.60M | ▲ 10.95M | ▼ 7.64M | ▼ 5.62M | ▼ 3.10M | ▼ 2.89M |
General And Administrative Expenses | 2.54M | ▼ -5.96M | ▲ 0.00 | 0.00 | ▼ -22.19M | ▲ 19.49M | ▼ -562.00K |
Selling And Marketing Expenses | 9.20M | ▼ 8.98M | ▼ 0.00 | 0.00 | ▲ 25.29M | ▼ 10.11M | ▼ 3.68M |
Selling General And Administrative Expenses | 3.62M | ▼ 3.01M | ▼ 2.95M | ▲ 3.47M | ▼ 3.10M | ▲ 4.14M | ▼ 3.12M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 13.20M | ▼ 12.61M | ▲ 13.90M | ▼ 11.11M | ▼ 8.72M | ▼ 7.25M | ▼ 6.00M |
Cost And Expenses | 15.48M | ▲ 15.56M | ▲ 16.66M | ▼ 14.26M | ▼ 11.11M | ▲ 16.10M | ▼ 8.60M |
Interest Income | 99.00K | ▲ 180.00K | ▼ 79.00K | ▼ -2.00K | ▼ -65.00K | ▲ -37.00K | ▲ 513.00K |
Interest Expense | 1.86M | ▲ 2.09M | ▲ 2.52M | ▼ 908.00K | ▼ 650.00K | ▲ 774.00K | ▼ 390.00K |
Depreciation And Amortization | 414.00K | ▼ 412.00K | ▼ 291.00K | ▼ 259.00K | ▼ 210.00K | ▲ 313.00K | ▲ 322.00K |
Ebitda | 12.06M | ▼ 2.79M | ▲ 2.92M | ▼ -5.76M | ▲ -2.29M | ▼ -5.30M | ▲ -4.53M |
Ebitda Ratio | 0.45 | ▼ 0.16 | ▼ 0.15 | ▼ -0.67 | ▲ -0.27 | ▼ -0.51 | ▼ -1.21 |
Operating Income | 11.54M | ▼ 2.20M | ▲ 2.84M | ▼ -5.71M | ▲ -2.50M | ▼ -5.62M | ▲ -4.86M |
Operating Income Ratio | 0.43 | ▼ 0.12 | ▲ 0.15 | ▼ -0.67 | ▲ -0.29 | ▼ -0.54 | ▼ -1.30 |
Total Other Income Expenses Net | -1.76M | ▼ -1.91M | ▼ -2.44M | ▲ -908.00K | ▲ -715.00K | ▼ -811.00K | ▲ 123.00K |
Income Before Tax | 9.78M | ▼ 291.00K | ▲ 397.00K | ▼ -6.67M | ▲ -3.21M | ▼ -6.43M | ▲ -4.73M |
Income Before Tax Ratio | 0.36 | ▼ 0.02 | ▲ 0.02 | ▼ -0.78 | ▲ -0.37 | ▼ -0.61 | ▼ -1.26 |
Income Tax Expense | 99.00K | ▲ 180.00K | ▼ -212.00K | ▲ 908.00K | ▼ 530.00K | ▼ -382.00K | ▲ -138.00K |
Net Income | 9.78M | ▼ 291.00K | ▲ 397.00K | ▼ -6.67M | ▲ -3.74M | ▼ -6.04M | ▲ -4.60M |
Net Income Ratio | 0.36 | ▼ 0.02 | ▲ 0.02 | ▼ -0.78 | ▲ -0.43 | ▼ -0.58 | ▼ -1.23 |
Eps | 0.66 | ▼ 0.02 | ▼ 0.01 | ▼ -0.15 | ▲ -0.07 | ▼ -0.08 | ▲ -0.06 |
Eps Diluted | 0.66 | ▼ 0.02 | ▼ 0.01 | ▼ -0.15 | ▲ -0.07 | ▼ -0.08 | ▲ -0.06 |
Weighted Average Shs Out | 14.83M | ▲ 17.38M | ▲ 32.86M | ▲ 45.28M | ▲ 51.34M | ▲ 72.95M | ▲ 73.04M |
Weighted Average Shs Out Dil | 14.84M | ▲ 17.38M | ▲ 32.86M | ▲ 45.56M | ▲ 51.34M | ▲ 72.95M | ▲ 73.04M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 37.81M | ▼ 17.79M | ▲ 18.27M | ▲ 38.99M | ▼ 17.11M | ▲ 23.63M | ▲ 27.21M |
Short Term Investments | 0.00 | 0.00 | ▲ 20.28M | ▲ 38.99M | ▼ 5.07M | ▲ 20.93M | ▲ 21.28M |
Cash And Short Term Investments | 37.81M | ▼ 17.79M | ▲ 38.55M | ▲ 38.99M | ▼ 22.18M | ▲ 44.56M | ▲ 48.49M |
Net Receivables | 4.73M | ▼ 4.70M | ▼ 2.00M | ▲ 3.44M | ▲ 4.59M | ▲ 5.27M | ▼ 3.76M |
Inventory | 8.57M | ▼ 8.16M | ▲ 13.08M | ▲ 17.95M | ▼ 16.80M | ▲ 19.05M | ▲ 22.35M |
Other Current Assets | 863.00K | ▼ 698.00K | ▲ 2.10M | ▼ 1.29M | ▼ 536.00K | ▲ 1.06M | ▼ 812.00K |
Total Current Assets | 52.98M | ▼ 32.48M | ▲ 55.72M | ▲ 61.67M | ▼ 44.88M | ▲ 69.93M | ▲ 75.40M |
Property Plant Equipment Net | 6.39M | ▲ 10.95M | ▼ 10.41M | ▼ 9.92M | ▼ 9.64M | ▲ 10.88M | ▼ 10.66M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 3.09M | ▲ 3.23M |
Other Non Current Assets | 1.76M | ▲ 1.96M | ▼ 1.80M | ▲ 2.08M | ▼ 1.27M | ▼ 528.00K | ▲ 531.00K |
Total Non Current Assets | 8.15M | ▲ 12.91M | ▼ 12.21M | ▼ 12.00M | ▼ 10.91M | ▲ 14.50M | ▼ 14.42M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Total Assets | 61.13M | ▼ 45.39M | ▲ 67.93M | ▲ 73.67M | ▼ 55.79M | ▲ 84.43M | ▲ 89.83M |
Account Payables | 5.21M | ▲ 6.50M | ▲ 7.22M | ▼ 6.99M | ▼ 5.86M | ▼ 4.32M | ▼ 3.15M |
Short Term Debt | 0.00 | ▲ 5.44M | ▲ 59.93M | ▼ 1.21M | ▼ 1.12M | ▲ 21.66M | ▲ 21.87M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 530.00K | ▲ 2.88M | 2.88M |
Deferred Revenue | 9.87M | ▲ 16.34M | ▼ 5.39M | ▲ 8.55M | ▲ 13.18M | ▼ 2.88M | ▲ 11.04M |
Other Current Liabilities | 10.27M | ▲ 11.91M | ▲ 13.93M | ▲ 16.43M | ▼ 12.27M | ▲ 16.67M | ▲ 18.77M |
Total Current Liabilities | 25.35M | ▲ 40.18M | ▲ 86.47M | ▼ 33.18M | ▼ 32.43M | ▲ 45.53M | ▲ 54.83M |
Long Term Debt | 47.97M | ▲ 55.49M | ▼ 4.47M | ▲ 32.26M | ▲ 32.36M | ▼ 4.62M | ▼ 4.50M |
Deferred Revenue Non Current | 33.03M | ▼ 16.98M | ▼ 1.72M | ▲ 11.79M | ▼ 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 2.37M | ▲ 2.57M | ▼ 2.26M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 5.29M | ▼ 509.00K | ▼ 51.00K | ▲ 2.47M | ▼ 1.64M | ▼ 714.00K | ▼ 712.00K |
Total Non Current Liabilities | 88.66M | ▼ 75.54M | ▼ 8.50M | ▲ 46.53M | ▼ 34.00M | ▼ 5.34M | ▼ 5.21M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Capital Lease Obligations | 0.00 | ▲ 5.67M | ▲ 5.89M | ▼ 5.58M | ▼ 5.29M | ▼ 4.62M | ▼ 4.50M |
Total Liabilities | 114.01M | ▲ 115.71M | ▼ 94.97M | ▼ 79.70M | ▼ 66.43M | ▼ 50.87M | ▲ 60.04M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Common Stock | 148.00K | ▼ 15.00K | ▲ 35.00K | ▲ 46.00K | ▲ 54.00K | ▲ 73.00K | 73.00K |
Retained Earnings | -322.55M | ▼ -340.83M | ▼ -347.35M | ▼ -374.93M | ▼ -389.86M | ▲ -381.55M | ▼ -385.92M |
Accumulated Other Comprehensive Income Loss | -29.12M | ▼ -30.70M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 298.64M | ▲ 301.20M | ▲ 320.28M | ▲ 368.85M | ▲ 379.17M | ▲ 415.05M | ▲ 415.63M |
Total Stockholders Equity | -52.88M | ▼ -70.32M | ▲ -27.04M | ▲ -6.04M | ▼ -10.64M | ▲ 33.57M | ▼ 29.79M |
Total Equity | -52.88M | ▼ -70.32M | ▲ -27.04M | ▲ -6.04M | ▼ -10.64M | ▲ 33.57M | ▼ 29.79M |
Total Liabilities And Stockholders Equity | 61.13M | ▼ 45.39M | ▲ 67.93M | ▲ 73.67M | ▼ 55.79M | ▲ 84.43M | ▲ 89.83M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 61.13M | ▼ 45.39M | ▲ 67.93M | ▲ 73.67M | ▼ 55.79M | ▲ 84.43M | ▲ 89.83M |
Total Investments | 0.00 | 0.00 | ▲ 20.28M | ▲ 38.99M | ▼ 5.07M | ▲ 20.93M | ▲ 21.28M |
Total Debt | 47.97M | ▲ 60.93M | ▲ 64.40M | ▼ 33.47M | ▲ 33.47M | ▼ 26.28M | ▲ 26.37M |
Net Debt | 10.16M | ▲ 43.13M | ▲ 46.14M | ▼ -5.52M | ▲ 16.36M | ▼ 2.65M | ▼ -837.00K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | 9.78M | ▼ 291.00K | ▲ 397.00K | ▼ -6.67M | ▲ -3.74M | ▼ -6.04M | ▲ -4.60M |
Depreciation And Amortization | 414.00K | ▼ 412.00K | ▼ 291.00K | ▼ 259.00K | ▲ 275.00K | ▲ 313.00K | ▲ 322.00K |
Deferred Income Tax | 67.00K | ▼ -119.00K | ▲ -23.00K | ▲ 8.00K | ▼ 0.00 | ▲ 3.09M | ▼ -138.00K |
Stock Based Compensation | 418.00K | ▼ 236.00K | ▲ 1.01M | ▼ 418.00K | ▲ 539.00K | ▲ 1.37M | ▼ 981.00K |
Change In Working Capital | -15.47M | ▲ -5.31M | ▼ -10.61M | ▲ 492.00K | ▼ 300.00K | ▲ 7.77M | ▲ 8.08M |
Accounts Receivables | 562.00K | ▲ 4.96M | ▼ 1.31M | ▲ 3.04M | ▲ 4.50M | ▼ 3.76M | ▼ 1.75M |
Inventory | -610.00K | ▼ -630.00K | ▲ 199.00K | ▼ -3.22M | ▲ -2.24M | ▲ 2.54M | ▼ -3.30M |
Accounts Payables | -244.00K | ▲ 2.74M | ▼ -970.00K | ▲ 1.39M | ▼ -4.80M | ▲ 1.48M | ▼ -1.41M |
Other Working Capital | -15.17M | ▲ -12.37M | ▲ -11.14M | ▲ -715.00K | ▲ 2.85M | ▼ 1.00K | ▲ 12.80M |
Other Non Cash Items | 781.00K | ▲ 801.00K | ▲ 1.38M | ▼ 403.00K | ▼ 15.00K | ▼ -2.91M | ▲ 5.87M |
Net Cash Provided By Operating Activities | -4.00M | ▲ -3.69M | ▼ -7.55M | ▲ -5.09M | ▲ -2.61M | ▲ 3.60M | ▲ 4.19M |
Investments In Property Plant And Equipment | -188.00K | ▲ -28.00K | ▼ -275.00K | ▼ -448.00K | ▲ -213.00K | ▼ -250.00K | ▼ -598.00K |
Acquisitions Net | 0.00 | 0.00 | 0.00 | ▼ -37.84M | ▲ 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | ▲ 7.50M | ▲ 37.84M | ▼ 16.00M | ▼ 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | ▲ 37.84M | ▼ 5.00M | ▼ 0.00 | 0.00 |
Other Investing Activities | 272.00K | ▼ 57.00K | ▲ 367.00K | ▼ 49.00K | ▼ -15.83M | ▲ -92.00K | ▲ -8.00K |
Net Cash Used For Investing Activities | 84.00K | ▼ 29.00K | ▲ 7.59M | ▲ 37.44M | ▼ 4.95M | ▼ -342.00K | ▼ -606.00K |
Debt Repayment | -4.75M | ▲ 0.00 | 0.00 | ▼ -4.05M | ▲ 0.00 | 0.00 | 0.00 |
Common Stock Issued | 0.00 | 0.00 | ▲ 4.87M | ▼ 0.00 | ▲ 4.08M | ▼ 0.00 | 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | ▼ -215.00K | ▲ 0.00 | ▲ 4.08M | ▼ -14.23M | ▲ 0.00 |
Net Cash Used Provided By Financing Activities | -4.75M | ▲ 0.00 | ▲ 4.65M | ▼ -4.05M | ▲ 4.08M | ▼ 0.00 | 0.00 |
Effect Of Forex Changes On Cash | -140.00K | ▲ 8.00K | ▲ 38.00K | ▲ 40.00K | ▼ -26.00K | ▼ -27.00K | ▲ -7.00K |
Net Change In Cash | -4.06M | ▲ -3.65M | ▲ 4.73M | ▲ 28.34M | ▼ 6.39M | ▼ 3.23M | ▲ 3.58M |
Cash At End Of Period | 37.81M | ▼ 17.79M | ▲ 18.27M | ▲ 38.99M | ▼ 17.11M | ▲ 23.63M | ▲ 27.21M |
Cash At Beginning Of Period | 41.87M | ▼ 21.44M | ▼ 13.53M | ▼ 10.64M | ▲ 10.72M | ▲ 20.41M | ▲ 23.63M |
Operating Cash Flow | -4.00M | ▲ -3.69M | ▼ -7.55M | ▲ -5.09M | ▲ -2.61M | ▲ 3.60M | ▲ 4.19M |
Capital Expenditure | -188.00K | ▲ -28.00K | ▼ -275.00K | ▼ -448.00K | ▲ -213.00K | ▼ -250.00K | ▼ -598.00K |
Free Cash Flow | -4.19M | ▲ -3.72M | ▼ -7.83M | ▲ -5.54M | ▲ -2.82M | ▲ 3.35M | ▲ 3.59M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)